We have located links that may give you full text access.
Transforaminal epidural Etanercept for the treatment of prolapsed lumbar intervertebral disc induced sciatica.
Journal of Clinical Orthopaedics and Trauma 2017 April
STUDY DESIGN: Hospital based prospective study.
OBJECTIVE: To study clinical response of transforaminal epidural Etanercept for lumbar prolapsed intervertebral disc induced sciatica.
METHOD: Patients presenting to O.P.D and Emergency services of our hospital were screened for inclusion and exclusion criteria & suitable candidates were enrolled in study. Patients received 2 transforaminal epidural injections of Etanercept 2 mg, 2 weeks apart, and were assessed for efficacy at 2 week, 1 month and 3 months after the second injection. Primary outcome was based on Visual Analog Scale for leg (VASL) and back pain (VASB) and secondary outcome was based on Modified Oswestry back related disability index (ODI).
RESULTS: 31 of 33 enrolled patients completed study. Patients showed clinically and statistically significant ( p < 0.001) reduction in VASL, VASB and ODI. There was no incidence of adverse events.
CONCLUSION: Epidural Etanercept is promising and effective non-operative treatment for patients with sciatica. But these results need to be confirmed by a randomized controlled trial.
OBJECTIVE: To study clinical response of transforaminal epidural Etanercept for lumbar prolapsed intervertebral disc induced sciatica.
METHOD: Patients presenting to O.P.D and Emergency services of our hospital were screened for inclusion and exclusion criteria & suitable candidates were enrolled in study. Patients received 2 transforaminal epidural injections of Etanercept 2 mg, 2 weeks apart, and were assessed for efficacy at 2 week, 1 month and 3 months after the second injection. Primary outcome was based on Visual Analog Scale for leg (VASL) and back pain (VASB) and secondary outcome was based on Modified Oswestry back related disability index (ODI).
RESULTS: 31 of 33 enrolled patients completed study. Patients showed clinically and statistically significant ( p < 0.001) reduction in VASL, VASB and ODI. There was no incidence of adverse events.
CONCLUSION: Epidural Etanercept is promising and effective non-operative treatment for patients with sciatica. But these results need to be confirmed by a randomized controlled trial.
Full text links
Trending Papers
Acute and non-acute decompensation of liver cirrhosis (47/130).Liver International : Official Journal of the International Association for the Study of the Liver 2024 March 2
Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2024 Update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM).Clinical Infectious Diseases 2024 March 6
Ten Influential Point-of-Care Ultrasound Papers: 2023 in Review.Journal of Intensive Care Medicine 2024 Februrary 20
Administration of methylene blue in septic shock: pros and cons.Critical Care : the Official Journal of the Critical Care Forum 2024 Februrary 17
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app